1. Home
  2. UAA vs TMDX Comparison

UAA vs TMDX Comparison

Compare UAA & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UAA
  • TMDX
  • Stock Information
  • Founded
  • UAA 1996
  • TMDX 1998
  • Country
  • UAA United States
  • TMDX United States
  • Employees
  • UAA N/A
  • TMDX N/A
  • Industry
  • UAA Apparel
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • UAA Consumer Discretionary
  • TMDX Health Care
  • Exchange
  • UAA Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • UAA 2.5B
  • TMDX 2.3B
  • IPO Year
  • UAA N/A
  • TMDX 2019
  • Fundamental
  • Price
  • UAA $5.95
  • TMDX $93.20
  • Analyst Decision
  • UAA Hold
  • TMDX Buy
  • Analyst Count
  • UAA 20
  • TMDX 10
  • Target Price
  • UAA $8.07
  • TMDX $120.11
  • AVG Volume (30 Days)
  • UAA 13.5M
  • TMDX 1.1M
  • Earning Date
  • UAA 05-13-2025
  • TMDX 05-08-2025
  • Dividend Yield
  • UAA N/A
  • TMDX N/A
  • EPS Growth
  • UAA N/A
  • TMDX N/A
  • EPS
  • UAA N/A
  • TMDX 1.01
  • Revenue
  • UAA $5,315,924,000.00
  • TMDX $441,540,000.00
  • Revenue This Year
  • UAA N/A
  • TMDX $25.33
  • Revenue Next Year
  • UAA N/A
  • TMDX $20.53
  • P/E Ratio
  • UAA N/A
  • TMDX $92.28
  • Revenue Growth
  • UAA N/A
  • TMDX 82.74
  • 52 Week Low
  • UAA $4.78
  • TMDX $55.00
  • 52 Week High
  • UAA $11.89
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • UAA 51.48
  • TMDX 63.43
  • Support Level
  • UAA $5.61
  • TMDX $89.10
  • Resistance Level
  • UAA $6.10
  • TMDX $95.71
  • Average True Range (ATR)
  • UAA 0.22
  • TMDX 4.15
  • MACD
  • UAA 0.06
  • TMDX -0.23
  • Stochastic Oscillator
  • UAA 65.44
  • TMDX 57.13

About UAA Under Armour Inc.

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: